An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging ; volume:8 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-15 ; date:12.2018
Scientific reports ; 8, Heft 1 (15.3.2018), 1-15, 12.2018

Creator: Wang, Xueying

Contributor: Kastanenka, Ksenia V.
Arbel-Ornath, Michal
Commins, Caitlin
Kuzuya, Akira
Lariviere, Amanda J.
Krafft, Grant A.
Hefti, Franz
Jerecic, Jasna
Bacskai, Brian J.
SpringerLink (Online service)

DOI: 10.1038/s41598-018-22979-2

URN: urn:nbn:de:1111-201805144533

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wang, Xueying
Kastanenka, Ksenia V.
Arbel-Ornath, Michal
Commins, Caitlin
Kuzuya, Akira
Lariviere, Amanda J.
Krafft, Grant A.
Hefti, Franz
Jerecic, Jasna
Bacskai, Brian J.
SpringerLink (Online service)

Other Objects (12)

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Stability of single and double layer fibrillar amyloid-β oligomers

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Origins of amyloid-β

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Selective amyloid-β lowering agents

Beta-amyloid oligomers: recent developments

Related objects

Reset password